Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × NIH × Carcinoma, Basal Cell × Clear all

Phase

Status

Completed 8 Unknown 2 Active not recruiting 2 Withdrawn 1 Recruiting 1

Sponsor Class

OTHER 7 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 11 Neoplasms 10 Multiple Myeloma 10 Breast Neoplasms 7 Colorectal Neoplasms 6 Neoplasm Metastasis 5 Melanoma 5 Carcinoma, Hepatocellular 5 Brain Neoplasms 5 Ovarian Neoplasms 4 Leukemia 4 Hematologic Neoplasms 4 Colonic Neoplasms 4 Triple Negative Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Sarcoma 3 Pancreatic Neoplasms 3 Neuroblastoma 3 Neoplasms, Plasma Cell 3 Mesothelioma, Malignant 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Liver Neoplasms 3 Leukemia, Myeloid, Acute 3 Glioblastoma 3 Wilms Tumor 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Recurrence 2

Interventions

Chemoprevention 1 Celecoxib 1 Biological Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00025051 2013-03-22

Celecoxib in Preventing Skin Cancer

National Cancer Institute (NCI)

Phase 2 Withdrawn

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡